Seegene Inc, a South Korean biotechnology firm, announced the launch of a SARS-CoV-2 variant diagnostic test capable of detecting new virus variants including the Delta and the Delta Plus that have become the dominant virus around the world.
India, already hit hard by the Delta variant of COVID-19, has labeled a closely related new variant -- dubbed "Delta Plus" -- as a "variant of concern."